ÂÜÀòÂÒÂ×

William P. Tew has over 40 years of entrepreneurial leadership experience in biopharmaceutical and medical device commercialization, FDA regulatory affairs, cGMP control, and university technology licensing. He founded Chesapeake Biological Laboratories (CBL) to advance pharmaceutical concepts in degenerative joint disease, leading to two successful FDA approvals and acquisition by Cangene Corp. Dr. Tew went on to found Glycosan BioSystems (acquired by OrthoCyte/BioTime) to commercialize medical devices and cell delivery products based on BioTime’s hyaluronan-based hydrogel technology, HyStem®. Dr. Tew also served as an Assistant Professor of Biochemistry, Associate Provost, and Assistant Dean of Licensing and Technology Development at the Johns Hopkins University School of Medicine.